TAKHZYRO is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥12 years of age.

Mobile site search icon.
Mobile navigation icon.

TAKHZYRO is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥12 years of age.

Resources for patients

Use the patient resources below to help explain TAKHZYRO to your patients and their caregivers.

TAKHZYRO® patient brochure.


Learn all about TAKHZYRO, from study results to dosing information and more.



Getting started with TAKHZYRO® brochure.

Getting Started Brochure

Get an overview of what to expect upon starting treatment with TAKHZYRO.



TAKHZYRO® Instructions for Use brochure.

TAKHZYRO Instructions for Use

Walk your patients through step-by-step instructions on how to inject TAKHZYRO.



TAKHZYRO® Travel Tips brochure.

TAKHZYRO Travel Tips Brochure

Help patients plan for travel with the considerations outlined, including HAE travel tips and information about the TAKHZYRO travel kit.


TAKHZYRO® Caregiver brochure.

TAKHZYRO Caregiver Brochure

Guide caregivers through helpful HAE information and useful tips on how they can support their loved ones taking TAKHZYRO.


Prescribing Information for TAKHZYRO®.

Prescribing Information

Provide the full Prescribing Information for TAKHZYRO to patients.



HAE attack plan document.

HAE Attack Plan

Fill this form out with your doctor and use it to explain HAE to others, including what steps to take in the event of an emergency.


Encourage patient education

Lexi, a real TAKHZYRO® patient.

Your patients might benefit from seeing how other people are reimagining their lives with TAKHZYRO. Encourage them to explore our video gallery.

Patients can watch here

Smartphone and texting bubble images - TAKHZYRO® patients can sign up for dosing reminders.

Some of your patients may need help remembering to take TAKHZYRO as you've prescribed. Encourage them to sign up for dosing reminders.

Patients can sign up here

HAEA: US Hereditary Angioedema Association logo.

Your HAE patients can continue to explore resources and connect with support offered through the US Hereditary Angioedema Association (HAEA).


Looking for more resources to support your patients and your practice?

Sign up for emails

References: 1. TAKHZYRO (lanadelumab-flyo) [prescribing information]. Lexington, MA: Dyax Corp 2018.